UA94031C2 - Препарат для перорального применения с непрерывным (постоянным) высвобождением при приеме фармацевтически активного ингредиента вместе с пищей - Google Patents

Препарат для перорального применения с непрерывным (постоянным) высвобождением при приеме фармацевтически активного ингредиента вместе с пищей

Info

Publication number
UA94031C2
UA94031C2 UAA200703512A UAA200703512A UA94031C2 UA 94031 C2 UA94031 C2 UA 94031C2 UA A200703512 A UAA200703512 A UA A200703512A UA A200703512 A UAA200703512 A UA A200703512A UA 94031 C2 UA94031 C2 UA 94031C2
Authority
UA
Ukraine
Prior art keywords
meal
sustained
achieve
release effect
dosage forms
Prior art date
Application number
UAA200703512A
Other languages
English (en)
Russian (ru)
Ukrainian (uk)
Inventor
Хенинг Блуме
Эрнст Мутчлер
Вернер Вайтчис
Original Assignee
Аристокон Фервальтунгс-Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Аристокон Фервальтунгс-Гмбх filed Critical Аристокон Фервальтунгс-Гмбх
Publication of UA94031C2 publication Critical patent/UA94031C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
UAA200703512A 2004-08-31 2005-08-30 Препарат для перорального применения с непрерывным (постоянным) высвобождением при приеме фармацевтически активного ингредиента вместе с пищей UA94031C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004042139A DE102004042139B4 (de) 2004-08-31 2004-08-31 Perorale Darreichungsformen zur Erzielung eines Retardierungseffektes nach der Arzneimitteleinnahme mit einer Mahlzeit

Publications (1)

Publication Number Publication Date
UA94031C2 true UA94031C2 (ru) 2011-04-11

Family

ID=35745691

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200703512A UA94031C2 (ru) 2004-08-31 2005-08-30 Препарат для перорального применения с непрерывным (постоянным) высвобождением при приеме фармацевтически активного ингредиента вместе с пищей

Country Status (7)

Country Link
US (1) US20090010906A1 (enExample)
EP (1) EP1814512A2 (enExample)
JP (1) JP2008511585A (enExample)
DE (1) DE102004042139B4 (enExample)
EA (1) EA013429B1 (enExample)
UA (1) UA94031C2 (enExample)
WO (1) WO2006024638A2 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007041588A1 (de) 2007-09-01 2009-03-05 Lts Lohmann Therapie-Systeme Ag Arzneimittel mit Hefe
CN103142552A (zh) * 2013-02-22 2013-06-12 广州科的信医药技术有限公司 一种洛伐他汀肠溶缓释微丸胶囊及其制备方法

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1139991A (en) * 1965-07-19 1969-01-15 Armour Pharma Stabilized enzyme composition
GB1573487A (en) * 1977-05-23 1980-08-28 Bristol Myers Co Bile acid binding composition
CA1182049A (en) * 1981-07-13 1985-02-05 Francis J. Sterbenz Apap antacid composition
DE3681348D1 (de) * 1985-06-11 1991-10-17 Teijin Ltd Oral-arzneizubereitung mit retardwirkung.
JPS61286322A (ja) * 1985-06-12 1986-12-16 Teijin Ltd 経口徐放性製剤
DE3543999A1 (de) * 1985-12-13 1987-06-19 Bayer Ag Hochreine acarbose
JPS62195323A (ja) * 1986-02-24 1987-08-28 Eisai Co Ltd 胃内滞留型粒子
JPS62207209A (ja) * 1986-03-07 1987-09-11 Teijin Ltd 経口徐放性製剤
US4929605A (en) * 1987-10-07 1990-05-29 Merrell Dow Pharmaceuticals Inc. Pharmaceutical composition for piperidinoalkanol derivatives
US5096714A (en) * 1988-06-28 1992-03-17 Hauser-Kuhrts, Inc. Prolonged release drug tablet formulations
US5004651A (en) * 1989-01-24 1991-04-02 Abbott Laboratories Stabilizing system for solid dosage forms
US4975281A (en) * 1989-01-30 1990-12-04 E. R. Squibb & Sons, Inc. Anti-ulcer composition
CA2030449A1 (en) * 1989-11-22 1991-05-23 Eric H. Kuhrts Prolonged release drug tablet formulations
US5683719A (en) * 1990-11-22 1997-11-04 British Technology Group Limited Controlled release compositions
GB9025372D0 (en) * 1990-11-22 1991-01-09 Nat Res Dev Pharmaceutical dosage forms
UA37214C2 (uk) * 1991-01-30 2001-05-15 Дзе Веллкам Фаундейшн Лімітед Таблетки, що диспергуються у воді, та спосіб їх виготовлення
YU48263B (sh) * 1991-06-17 1997-09-30 Byk Gulden Lomberg Chemische Fabrik Gmbh. Postupak za dobijanje farmaceutskog preparata na bazi pantoprazola
HU9203780D0 (en) * 1991-12-12 1993-03-29 Sandoz Ag Stabilized pharmaceutical products of hmg-coa reductase inhibitor and method for producing them
GB9224021D0 (en) * 1992-11-16 1993-01-06 Boots Co Plc Effervescent compositions
US6645988B2 (en) * 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6649186B1 (en) * 1996-09-20 2003-11-18 Ethypharm Effervescent granules and methods for their preparation
US6071539A (en) * 1996-09-20 2000-06-06 Ethypharm, Sa Effervescent granules and methods for their preparation
GB9704524D0 (en) * 1997-03-05 1997-04-23 Smithkline Beecham Plc Composition
US20010046473A1 (en) * 1997-04-18 2001-11-29 Jerome Besse Gastric-retained pharmaceutical composition and method for its use
US6235311B1 (en) * 1998-03-18 2001-05-22 Bristol-Myers Squibb Company Pharmaceutical composition containing a combination of a statin and aspirin and method
DK0976395T3 (da) * 1998-07-30 2005-11-14 Merck Sante Sas Tablet til langvarig afgivelse af et lægemiddel i maven
AP1659A (en) * 1998-09-14 2006-09-06 Ranbaxy Laboratories Ltd Orally administered controlled drug delivery system providing temporal and spatial control.
AP2002002410A0 (en) * 1999-08-04 2002-03-31 Ranbaxy Laboratories Ltd Hydrodynamically Balancing Oral Drug Delivery System
WO2003097018A1 (en) * 2002-02-04 2003-11-27 Ranbaxy Laboratories Limited Hydrodynamically balancing oral drug delivery system with biphasic release
GB0114069D0 (en) * 2001-06-08 2001-08-01 Smithkline Beecham Plc Composition
BR0211317A (pt) * 2001-07-04 2004-12-14 Sun Pharmaceutical Ind Ltd Sistema para a liberação controlada de uma droga por meio de retenção gástrica

Also Published As

Publication number Publication date
EA013429B1 (ru) 2010-04-30
DE102004042139B4 (de) 2009-06-10
US20090010906A1 (en) 2009-01-08
EA200700524A1 (ru) 2007-08-31
JP2008511585A (ja) 2008-04-17
WO2006024638A3 (de) 2007-04-05
WO2006024638A2 (de) 2006-03-09
DE102004042139A1 (de) 2006-03-02
EP1814512A2 (de) 2007-08-08

Similar Documents

Publication Publication Date Title
TW200730202A (en) Solid dosage form
GEP20105083B (en) A solid pharmaceutical dosage formulation
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
TW200744665A (en) Vitamin E succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof
TW200633716A (en) Compositions and methods for stabilizing active pharmaceutical ingredients
EA200501586A1 (ru) Фармацевтические продукты
MX2009004965A (es) Formas de dosificacion y co-administracion de un agonista de opioides y un antagonista de opioides.
CY1107906T1 (el) Φαρμακευτικη συνθεση που περιλαμβανει παραγωγα οιστετρολης για χρηση στην θεραπεια κατα του καρκινου
PT1299348E (pt) Compostos e composições para administração de agentes activos
FR2878161B1 (fr) Forme medicamenteuse orale, solide et concue pour eviter le mesusage
WO2005097076A3 (en) Low dose pharmaceutical products
MX2008002492A (es) Composiciones farmaceuticas que comprenden un farmaco dependiente del ph, un modificador del ph, y un agente retardante.
MXPA06010767A (es) Composicion farmaceutica anhidra que asocia un agente siliconado y principio activo solubilizado.
WO2004022002A3 (en) Combined immediate release and extended release analgesic composition
EA200970353A1 (ru) Комбинированное лекарственное средство
MY153109A (en) A solid pharmaceutical formulation
EA200701172A1 (ru) 2-алкокси-3,4,5-тригидроксиалкиламиды, их получение, композиции, их содержащие, и применение
EA200500672A1 (ru) Содержащие альфузозин композиции с отсроченным высвобождением
WO2006024638A3 (de) Perorale darreichungsformen zur erzielung eines retardierungseffektes nach der arzneimitteleinnahme mit einer mahlzeit
WO2006076097A3 (en) Stable non-crystalline formulation comprising losartan
ATE389402T1 (de) Sedierende nicht-benzodiazepin-formulierungen
WO2007009691A3 (en) Combination of substituted pyrazolines and anti -addictive agent
MX2009005329A (es) Composiciones farmaceuticas anticonvulsivas.
WO2008051565A3 (en) A drug-release composition having a therapeutic carrier
WO2007011958A3 (en) Intraoral dosage forms of glucagon